Document:

EX-4.2

 Exhibit 4.2 

CONTEXTLOGIC INC. 

AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

March 18, 2019 

 TABLE OF CONTENTS 

 

									
		  		  		  	 	Page	 
	1.	  	Registration Rights	  	 	2	 
				
		  	1.1	  	Definitions	  	 	2	 
				
		  	1.2	  	Request for Registration	  	 	4	 
				
		  	1.3	  	Company Registration	  	 	6	 
				
		  	1.4	  	Form S-3 Registration; Shelf Take-Downs	  	 	7	 
				
		  	1.5	  	Obligations of the Company	  	 	10	 
				
		  	1.6	  	Information from Holder	  	 	12	 
				
		  	1.7	  	Expenses of Registration	  	 	12	 
				
		  	1.8	  	Delay of Registration	  	 	13	 
				
		  	1.9	  	Indemnification	  	 	13	 
				
		  	1.10	  	Reports Under the 1934 Act	  	 	15	 
				
		  	1.11	  	Assignment of Registration Rights	  	 	16	 
				
		  	1.12	  	Limitations on Subsequent Registration Rights	  	 	16	 
				
		  	1.13	  	“Market Stand-Off” Agreement	  	 	16	 
				
		  	1.14	  	Termination of Registration Rights	  	 	18	 
			
	2.	  	Covenants of the Company	  	 	18	 
				
		  	2.1	  	Delivery of Financial Statements	  	 	18	 
				
		  	2.2	  	Inspection	  	 	19	 
				
		  	2.3	  	Termination of Information and Inspection Covenants	  	 	20	 
				
		  	2.4	  	Right of First Offer	  	 	20	 
				
		  	2.5	  	Proprietary Information and Inventions Agreements	  	 	22	 
				
		  	2.6	  	Successor Indemnification	  	 	22	 
				
		  	2.7	  	FCPA	  	 	22	 
				
		  	2.8	  	Confidentiality	  	 	22	 
				
		  	2.9	  	Termination of Certain Covenants	  	 	23	 
			
	3.	  	Miscellaneous	  	 	23	 
				
		  	3.1	  	Successors and Assigns	  	 	23	 
				
		  	3.2	  	Governing Law	  	 	23	 
				
		  	3.3	  	Counterparts; Facsimile	  	 	23	 
				
		  	3.4	  	Titles and Subtitles	  	 	23	 

  
 i 

					
	3.5	  	Notices	  	23
			
	3.6	  	Expenses	  	24
			
	3.7	  	Entire Agreement; Amendments and Waivers	  	24
			
	3.8	  	Severability	  	25
			
	3.9	  	Aggregation of Stock	  	25
			
	3.10	  	Additional Investors	  	25
			
	3.11	  	Dispute Resolution	  	25
			
	3.12	  	Acknowledgment	  	26
			
	3.13	  	Delays or Omissions	  	26
			
	3.14	  	Specific Enforcement	  	26
			
	3.15	  	Effect on Prior Agreement	  	26

  
 ii 

 AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 18th day of
March 2019, by and among CONTEXTLOGIC INC., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively
as the “Investors”. 
 RECITALS 

WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series
A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”), the Company’s Series C
Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”), the Company’s Series D Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”), the Company’s Series E
Preferred Stock, par value $0.0001 per share (the “Series E Preferred Stock”), the Company’s Series F Preferred Stock, par value $0.0001 per share (the “Series F Preferred Stock”), the Company’s Series G
Preferred Stock, par value $0.0001 per share (the “Series G Preferred Stock”) and/or the Company’s shares of common stock, par value $0.0001 per share (“Common Stock”), issued upon conversion thereof and
possess registration rights, information rights, rights of first offer and other rights pursuant to that certain Amended and Restated Investors’ Rights Agreement dated as of September 26, 2017 by and among the Company and such Existing
Investors (the “Prior Agreement”); 
 WHEREAS, the Prior Agreement may be amended, and any provision
therein waived, with the consent of the Company and the holders of a majority of the outstanding Registrable Securities (as such term is defined in the Prior Agreement); 

WHEREAS, the Existing Investors as holders of a majority of the outstanding Registrable Securities (as such term is
defined in the Prior Agreement) desire to terminate the Prior Agreement and to accept the rights created pursuant hereto in lieu of the rights granted to them under the Prior Agreement; and 

WHEREAS, certain Investors are parties to that certain Series H Preferred Stock Purchase Agreement, dated as of the
date hereof (as it may be amended from time to time), by and among the Company and certain of the Investors (the “Series H Agreement”), which provides that as a condition to the closing of the sale of the Series H Preferred Stock,
par value $0.0001 per share (the “Series H Preferred Stock” and collectively with the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock, the Series D Preferred Stock, the Series E Preferred Stock,
the Series F Preferred Stock and the Series G Preferred Stock, the “Preferred Stock”), this Agreement must be executed and delivered by such Investors, Existing Investors holding a majority of the outstanding Registrable Securities
(as such term is defined in the Prior Agreement), and the Company. 

 NOW, THEREFORE, in consideration of the mutual promises and covenants
set forth herein, the Company and the Existing Investors hereby agree that the Prior Agreement shall be superseded and replaced in its entirety by this Agreement, and the parties hereto further agree as follows:  

1. Registration Rights. The Company covenants and agrees as follows: 

1.1 Definitions. For purposes of this Agreement: 

(a) The term “1934 Act” means the Securities Exchange Act of 1934, as amended. 

(b) The term “Act” means the Securities Act of 1933, as amended. 

(c) The term “Affiliate” means, with respect to any specified Person, any other Person who or which,
directly or indirectly, controls, is controlled by, or is under common control with such specified Person, including, without limitation, any general partner, officer, director or manager of such person and any venture capital fund or other
investment entity now or hereafter existing that is controlled by one or more general partners, managing members or managers of, or is under common investment management with, such Person; provided, however, that (i) each
Wellington Investor shall be deemed to be an “Affiliate” of each other Wellington Investor, and (ii) an entity that is an “Affiliate” of a Wellington Investor shall not be deemed to be an “Affiliate” of any other
Wellington Investor unless such entity is a Wellington Investor (and, for the avoidance of doubt, an “Affiliate” of such entity shall not be deemed an “Affiliate” of any Wellington Investor solely by virtue of being an
“Affiliate” of such entity). For the avoidance of doubt, with respect to The Founders Fund V, LP, “Affiliate” shall include Founders Fund, LLC; Founders Fund V Management LLC; The Founders Fund V, LP; The Founders Fund V
Principals Fund, LP; and The Founders Fund V Entrepreneurs Fund, LP; Lembas IV (or, in the alternative, one (1) similar Founders Fund investment vehicle); Founders Fund VI Management LLC; The Founders Fund VI, LP; The Founders Fund VI
Principals Fund, LP; and The Founders Fund VI Entrepreneurs Fund, LP; Peter Thiel, up to three (3) Founders Fund employee investment vehicles, or any partner or affiliate of any Permitted Founders Fund Entity, or any retirement accounts held on
behalf of any such partner. 
 (d) The term “Board” means the Company’s Board of Directors, as
constituted from time to time. 
 (e) The term “Form S-3” means
such form under the Act as in effect on the date hereof or any registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company
with the SEC. 
 (f) The term “Free Writing Prospectus” means a free-writing prospectus, as defined in
Rule 405. 
 (g) The term “General Atlantic” means General Atlantic (WI), L.P. or any of its Affiliates or
permitted transferees that hold Registrable Securities. 

  
 2 

 (h) The term “Holder” means any Person owning or having
the right to acquire Registrable Securities or any assignee thereof in accordance with Section 1.11 hereof. 
 (i) The
term “Initial Offering” means the Company’s first firm commitment underwritten public offering of its Common Stock under the Act. 

(j) The term “Minimum Valuation” means $8,750,000,000. 

(k) The term “Person” means any individual, corporation, partnership, trust, limited liability company,
association or other entity. 
 (l) The terms “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or
document. 
 (m) The term “Registrable Securities” means (i) the Common Stock issuable or issued upon
conversion of the Preferred Stock, (ii) any Common Stock acquired after the date of this Agreement in a secondary acquisition approved by the Board where the Board specifically references this Subsection (m)(ii) in its approval and states that
such shares shall be Registrable Securities, and (iii) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in
exchange for, or in replacement of, the shares referenced in (i) or (ii) above, excluding in all cases, however, any Registrable Securities sold by a Person in a transaction in which his rights under this Section 1 are not assigned. In
addition, the number of shares of Registrable Securities outstanding shall equal the aggregate of the number of shares of Common Stock outstanding that are, and the number of shares of Common Stock issuable pursuant to then exercisable or
convertible securities that are, Registrable Securities. 
 (n) The term “Requisite Parties” means
(i) the holders of a majority of the voting power of outstanding Preferred Stock and shares of Common Stock issued upon conversion of the Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis), (ii) the holders of a majority of the outstanding shares of Series E Preferred Stock (voting as a separate series and on an as-converted basis), (iii) the
Series F Requisite Holders, (iv) the Series G Requisite Holders and (v) the Series H Requisite Holders. 
 (o)
The term “Restated Certificate” shall mean the Company’s Amended and Restated Certificate of Incorporation, as amended and/or restated from time to time. 

(p) The term “Rule 144” shall mean Rule 144 under the Act. 

(q) The term “Rule 144(b)(1)(i)” shall mean subsection (b)(1)(i) of Rule 144 under the Act as it applies to
Persons who have held shares for more than one (1) year. 
 (r) The term “Rule 405” shall mean Rule
405 under the Act. 

  
 3 

 (s) The term “SEC” shall mean the Securities and Exchange
Commission. 
 (t) The term “Series F Requisite Holders” means: 

(i) So long as Republic Technologies Pte. Ltd. owns at least 50% of the shares of Series F Preferred Stock originally issued
to it, Republic Technologies Pte. Ltd. 
 (ii) In the event Republic Technologies Pte. Ltd. owns less than 50% of the
shares of Series F Preferred Stock originally issued to it, the holders of a majority of the then outstanding shares of Series F Preferred Stock (voting as a separate series). 

(u) The term “Series G New Investors” means Investors that, together with any of their respective
Affiliates, did not purchase shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series F Preferred Stock from the Company. 

(v) The term “Series G Requisite Holders” means 

(i) So long as the Series G New Investors own at least 50% of the shares of Series G Preferred Stock originally issued to the
Series G New Investors, (i) the holders of a majority of the then outstanding shares of Series G Preferred Stock held by the Series G New Investors and (ii) the holders of a majority of the then outstanding shares of Series G Preferred
Stock (voting as a separate series). 
 (ii) In the event the Series G New Investors own less than 50% of the shares of
Series G Preferred Stock originally issued to the Series G New Investors, the holders of a majority of the then outstanding shares of Series G Preferred Stock (voting as a separate series). 

(w) The term “Series H Requisite Holders” means the holders of a majority of the then outstanding shares of
Series H Preferred Stock (voting as a separate series and on an as-converted basis). 

(x) The term “Wellington” means Wellington Management Company LLP and any successor or affiliated investment
advisor or subadvisor thereof to the Wellington Investors. 
 (y) The term “Wellington Investors” means
Investors, or permitted transferees of Registrable Securities held by Wellington Investors, that are advisory or subadvisory clients of Wellington. 

1.2 Request for Registration. 

(a) Subject to the conditions of this Section 1.2, if the Company shall receive at any time after the earlier of
(i) June 9, 2021 and (ii) one hundred eighty (180) days after the effective date of the Initial Offering, a written request from the Holders of fifty percent 

  
 4 

 
(50%) or more of the Registrable Securities then outstanding (for purposes of this Section 1.2, the “Initiating Holders”) that the Company file a registration statement
under the Act covering the registration of Registrable Securities with an anticipated aggregate offering price, before underwriting discounts, commissions and fees, of at least $15,000,000, then the Company shall, within twenty (20) days of the
receipt thereof, give written notice of such request to all Holders, and subject to the limitations of this Section 1.2, use all commercially reasonable efforts to effect, as soon as practicable, the registration under the Act of all
Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty (20) days of the mailing of the Company’s notice pursuant to this Section 1.2(a). 

(b) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an
underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.2, and the Company shall include such information in the written notice referred to in Section 1.2(a). In such event the right of any
Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise
mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in
customary form with the underwriter or underwriters selected for such underwriting by those Initiating Holders holding a majority of the Registrable Securities held by all Initiating Holders (which underwriter or underwriters shall be reasonably
acceptable to the Company). Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Company in writing that marketing factors require a limitation on the number of securities underwritten (including Registrable
Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares that may be included in the underwriting shall be allocated to the Holders of such
Registrable Securities pro rata based on the number of Registrable Securities held by all such Holders (including the Initiating Holders). In no event shall any Registrable Securities be excluded from such underwriting unless all other securities
are first excluded. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. 

(c) Notwithstanding the foregoing, the Company shall not be required to effect a registration pursuant to this
Section 1.2: 
 (i) in any particular jurisdiction in which the Company would be required to execute a general consent
to service of process in effecting such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Act; or 

(ii) after the Company has effected two (2) registrations pursuant to this Section 1.2, and such registrations have
been declared or ordered effective; or 
 (iii) during the period starting with the date sixty (60) days prior to the
Company’s good faith estimate of the date of the filing of and ending on a date one hundred eighty (180) days following the effective date of a Company-initiated registration 

  
 5 

 
subject to Section 1.3 below, provided that the Company is actively employing in good faith all commercially reasonable efforts to cause such registration statement to become
effective; or 
 (iv) if the Initiating Holders propose to dispose of Registrable Securities that may be registered on Form
S-3 pursuant to Section 1.4 hereof; or 
 (v) if the Company shall furnish to
Holders requesting a registration statement pursuant to this Section 1.2 a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board, it would be seriously
detrimental to the Company and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of
the request of the Initiating Holders, provided that such right shall be exercised by the Company not more than once in any twelve (12) month period and provided further that the Company shall not register any securities
for the account of itself or any other stockholder during such ninety (90) day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate
reorganization or transaction under Rule 145 of the Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable
Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered). 

1.3 Company Registration. 

(a) If (but without any obligation to do so) the Company proposes to register (including for this purpose a registration
effected by the Company for stockholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering of such securities (other than (i) a registration relating to a demand pursuant to
Section 1.2, (ii) a registration relating solely to the sale of securities of participants in a Company stock plan, (iii) a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, (iv) a registration
on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or (v) a registration in which the only Common Stock being
registered is Common Stock issuable upon conversion of debt securities that are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given
within twenty (20) days after mailing of such notice by the Company in accordance with Section 3.5, the Company shall, subject to the provisions of Section 1.3(c), use all commercially reasonable efforts to cause to be registered
under the Act all of the Registrable Securities that each such Holder requests to be registered. 
 (b) Right to
Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 1.3 prior to the effectiveness of such registration whether or not any Holder has elected to include
securities in such registration. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 1.7 hereof. 

  
 6 

 (c) Underwriting Requirements. In connection with any offering
involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under this Section 1.3 to include any of the Holders’ securities in such underwriting unless they accept the terms of the
underwriting as agreed upon between the Company and the underwriters selected by the Company (or by other Persons entitled to select the underwriters) and enter into an underwriting agreement in customary form with such underwriters, and then only
in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by stockholders to be included in
such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only
that number of such securities, including Registrable Securities, that the underwriters determine in their sole discretion will not jeopardize the success of the offering. In no event shall any Registrable Securities be excluded from such offering
unless all other stockholders’ securities have been first excluded. In the event that the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable
Securities that are included in such offering shall be apportioned pro rata among the selling Holders based on the number of Registrable Securities held by all selling Holders or in such other proportions as shall mutually be agreed to by all such
selling Holders. Notwithstanding the foregoing, in no event shall the amount of securities of the selling Holders included in the offering be reduced below thirty percent (30%) of the total amount of securities included in such offering, unless such
offering is the Initial Offering, in which case the selling Holders may be excluded if the underwriters make the determination described above and no other stockholder’s securities are included in such offering. For purposes of the preceding
sentence concerning apportionment, for any selling stockholder that is a Holder of Registrable Securities and that is a venture capital fund, partnership, limited liability company or corporation, the affiliated venture capital funds, partners,
members, retired partners, retired members and stockholders of such Holder, or the estates and family members of any such partners, members and retired partners and any trusts for the benefit of any of the foregoing Persons shall be deemed to be a
single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned by all such related entities and individuals. 

Registrations effected pursuant to this Section 1.3 shall not be counted as requests for registration effected pursuant
to Section 1.2 of this Agreement. 
 1.4 Form S-3 Registration; Shelf
Take-Downs. After the Initial Offering and after such time as the Company is eligible to register securities on Form S-3, the Company shall use commercially reasonable efforts to qualify for registration
on Form S-3 or any comparable or successor form, including a registration statement covering the sale or distribution of Registrable Securities from time to time by the Holders on a delayed or continuous basis
pursuant to Rule 415 of the Act (a “Shelf Registration”). In case the Company shall receive from the Holders of Registrable Securities with an aggregate value of at least $5,000,000 (for purposes of this Section 1.4, the
“S-3 Initiating Holders”) a written request or requests that the Company effect a registration on Form S-3, including a Shelf Registration, and any
related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company shall: 

  
 7 

 (a) promptly give written notice of the proposed registration, and any
related qualification or compliance, to all other Holders; and 
 (b) use all commercially reasonable efforts to effect, as
soon as practicable, such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are
specified in such request, together with all or such portion of the Registrable Securities of any other Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice
from the Company, provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance or Underwritten Takedown or Shelf Take-Down, pursuant to this Section 1.4: 

(i) if Form S-3 is not available for such offering by the Holders; 

(ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such
registration or Underwritten Takedown or Shelf Take-Down, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $5,000,000;

 (iii) if the Company shall furnish to all Holders requesting a registration statement or Underwritten Takedown or Shelf
Take-Down pursuant to this Section 1.4 a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board, it would be seriously detrimental to the Company and its
stockholders for such registration statement or Underwritten Takedown or Shelf Take-Down to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after
receipt of the request of the S-3 Initiating Holders or the receipt of the Shelf Offering Request, provided that such right shall be exercised by the Company not more than twice in any twelve
(12) month period and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period (other than a registration relating solely to the
sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a registration on any form that does not include substantially the same information as would
be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt that are also being
registered); 
 (iv) if the Company has, within the twelve (12) month period preceding the date of such request,
already effected one (1) registration or Underwritten Take-Down (not including Shelf Take-Downs that are not Underwritten Take-Downs) on Form S-3 pursuant to this Section 1.4; 

  
 8 

 (v) in any particular jurisdiction in which the Company would be required
to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance; or 

(vi) if the Company, within thirty (30) days of receipt of the request of such
S-3 Initiating Holders or the receipt of the Shelf Offering Request, gives notice of its bona fide intention to effect the filing of a registration statement with the SEC within one hundred twenty
(120) days of receipt of such request (other than a registration effected solely to qualify an employee benefit plan or to effect a business combination pursuant to Rule 145), provided that the Company is actively employing in good faith all
commercially reasonable efforts to cause such registration statement to become effective; or 
 (vii) during the period
starting with the date thirty (30) days prior to the Company’s good faith estimate of the date of the filing of and ending on a date ninety (90) days following the effective date of a Company-initiated registration subject to
Section 1.3 above, provided that the Company is actively employing in good faith all commercially reasonable efforts to cause such registration statement to become effective. 

(c) If the S-3 Initiating Holders intend to distribute the Registrable Securities
covered by their request by means of an underwriting or intend for the registration to be a Shelf Registration, they shall so advise the Company as a part of their request made pursuant to this Section 1.4 and the Company shall include such
information in the written notice referred to in Section 1.4(a). The provisions of Section 1.2(b) shall be applicable to such request (with the substitution of Section 1.4 for references to Section 1.2). 

(d) Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities and other
securities so requested to be registered as soon as practicable after receipt of the request or requests of the S-3 Initiating Holders. Registrations effected pursuant to this Section 1.4 shall not be
counted as requests for registration effected pursuant to Section 1.2. 
 (e) In the event that a Shelf Registration
is effective, the Holders shall have the right at any time or from time to time, on no more than two (2) occasions per year, to elect to sell pursuant to an offering (including an underwritten offering (an “Underwritten
Takedown”)) Registrable Securities available for sale pursuant to such Shelf Registration (“Shelf Registrable Securities”), so long as such Shelf Registration remains in effect and provided that the aggregate value of the
offering is at least $5,000,000. The Holders shall make such election by delivering to the Company a written request (a “Shelf Offering Request”) for such offering specifying the number of Shelf Registrable Securities that such
Holders desire to sell pursuant to such offering (the “Shelf Take-Down”). In the case of an Underwritten Takedown, as promptly as practicable, but no later than five (5) business days after receipt of a Shelf Offering Request,
the Company shall give written notice (the “Shelf Offering Notice”) of such Shelf Offering Request to all other holders of Shelf Registrable Securities. The Company shall include in such offering the Shelf Registrable Securities of
any other Holder that shall have made a written request to the Company for inclusion in such Shelf Take-Down (which request shall specify the maximum number of Shelf Registrable Securities intended to be sold by such Holder) within ten
(10) days after the receipt of the Shelf Offering Notice. The Company shall, as expeditiously as 

  
 9 

 
possible (and in any event within ten (10) days after the receipt of a Shelf Offering Request, unless a longer period is agreed to by the Holders), use commercially reasonable efforts to
facilitate such Shelf Take-Down. If the Holders request an Underwritten Takedown, then the Company shall have no obligation to effect such Underwritten Takedown if the Company has, within the twelve (12) month period preceding the date of such
request, already effected one (1) Underwritten Takedown pursuant to this Section 1.4. The Holders shall be permitted to sell Registrable Securities pursuant to the Shelf Take-Down for a period of thirty (30) days from the date of the
prospectus supplement relating to such Shelf Take-Down. 
 (i) For any Shelf Take-Down that is conducted as an underwritten
offering, the right of each Holder to have Registrable Securities included in a Shelf Take-Down shall be conditioned upon each Holder complying with the provisions of Section 1.2(b) hereof, as if such Shelf Take-Down were a registration
pursuant to Section 1.2(a). 
 (ii) Shelf Take-Downs effected pursuant to this Section 1.4 shall not be counted
as requests for registration effected pursuant to Section 1.2 of this Agreement. 
 1.5 Obligations of the
Company. Whenever required under this Section 1 to effect the registration of any Registrable Securities or effect a Shelf Take-Down, the Company shall, as expeditiously as reasonably possible: 

(a) in the case of effecting the registration of any Registrable Securities, prepare and file with the SEC a registration
statement with respect to such Registrable Securities and use all commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered
thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the Registration Statement has been completed; provided, however, that in the case
of any registration of Registrable Securities on Form S-3 which are intended to be offered on a continuous or delayed basis, such one hundred twenty (120) day period shall be extended, if necessary, to
keep the registration statement continuously effective, supplemented and amended to the extent necessary to ensure that it is available for sales of such Registrable Securities, and to ensure that it conforms with the requirements of this Agreement,
the Act and the policies, rules and regulations of the SEC as announced from time to time, until the earlier of when (i) the Holders have sold all such Registrable Securities and (ii) such time as the registration statement expires; 

(b) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in
connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement and, in connection with any registration on Form S-3, use reasonable, diligent efforts to timely file all reports required under the 1934 Act in order to maintain the right to continue to use such Form S-3; 

  
 10 

 (c) furnish to the Holders such number of copies of a prospectus, including
a preliminary prospectus and any Free Writing Prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) use all commercially reasonable efforts to register and qualify the securities covered by such registration statement
under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or
to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service of process in such jurisdiction; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement,
in usual and customary form, with the managing underwriter of such offering; 
 (f) notify each Holder of Registrable
Securities covered by such registration statement at any time when a prospectus or Free Writing Prospectus (to the extent prepared by or on behalf of the Company) relating thereto is required to be delivered under the Act of the happening of any
event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing, and, at the request of any such Holder, the Company will, as soon as reasonably practicable, file and furnish to all such Holders a supplement or amendment to such prospectus or
Free Writing Prospectus (to the extent prepared by or on behalf of the Company) so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a material fact or omit to
state any fact necessary to make the statements therein not misleading in light of the circumstances under which they were made; 

(g) cause all such Registrable Securities registered pursuant to this Section 1 to be listed on a national exchange or
trading system and on each securities exchange and trading system on which similar securities issued by the Company are then listed; 

(h) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and a CUSIP
number for all such Registrable Securities, in each case not later than the effective date of such registration; 
 (i)
promptly make available for inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or
selected by the selling Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information
reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in
connection therewith; 

  
 11 

 (j) notify each selling Holder, promptly after the Company receives notice
thereof, of the time when such registration statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 

(k) after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the
Company amend or supplement such registration statement or prospectus. 
 Notwithstanding the provisions of this
Section 1, the Company shall be entitled to postpone or suspend, for a reasonable period of time, the filing, effectiveness or use of, or trading under, any registration statement if, in the good faith judgment of the Board, the Board
determines that any such filing or the sale of any securities pursuant to such registration statement would: 
 (i)
materially impede, delay or interfere with any material pending or proposed financing, acquisition, corporate reorganization or other similar transaction involving the Company for which the Board has authorized negotiations; 

(ii) materially adversely impair the consummation of any pending or proposed material offering or sale of any class of
securities by the Company; or 
 (iii) require disclosure of material nonpublic information that, if disclosed at such
time, would be materially harmful to the interests of the Company and its stockholders; provided, however, that during any such period all executive officers and directors of the Company are also prohibited from selling securities of
the Company (or any security of any of the Company’s subsidiaries or affiliates) other than through pre-existing trading plans pursuant to Rule 10b5-1 of the
Exchange Act. 
 In the event of the suspension of effectiveness of any registration statement pursuant to this
Section 1.5, the applicable time period during which such registration statement is to remain effective shall be extended by that number of days equal to the number of days the effectiveness of such registration statement was suspended. 

1.6 Information from Holder. It shall be a condition precedent to the obligations of the Company to take any action
pursuant to this Section 1 with respect to the Registrable Securities or Shelf Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it,
and the intended method of disposition of such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities or to effect a Shelf Take-Down or an Underwritten Takedown. 

1.7 Expenses of Registration. All expenses other than underwriting discounts and commissions incurred in connection
with registrations, filings or qualifications pursuant to Sections 1.2, 1.3 and 1.4, including, without limitation, all registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the
Company and the reasonable fees and disbursements of one counsel for the selling Holders (not to exceed $50,000) shall be borne by the Company. Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any
registration proceeding begun pursuant to Section 1.2 or 

  
 12 

 
Section 1.4 if the registration request or Shelf Offering Request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered or
included in a the Shelf Take-Down (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration or Shelf Take-Down), unless, in the
case of a registration requested under Section 1.2, the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 1.2 or in the case of a Shelf Take-Down, such Holders
agree to forfeit their right to a Shelf Take-Down for one year and provided, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company
from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such
expenses and shall retain their rights pursuant to Section 1.2 and 1.4. 
 1.8 Delay of Registration. No Holder
shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

1.9 Indemnification. In the event any Registrable Securities are included in a registration statement under this
Section 1: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the
partners, members, officers, directors and stockholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Act) for such Holder and each Person, if any, who controls such Holder or underwriter within
the meaning of the Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the
Act, the 1934 Act or any state securities laws, insofar as such losses, claims, damages, or liabilities (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any of the following statements,
omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus, final prospectus, or Free
Writing Prospectus contained therein or any amendments or supplements thereto, any issuer information (as defined in Rule 433 of the Act) filed or required to be filed pursuant to Rule 433(d) under the Act or any other document incident to such
registration prepared by or on behalf of the Company or used or referred to by the Company, (ii) the omission or alleged omission to state in such registration statement a material fact required to be stated therein, or necessary to make the
statements therein not misleading or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, and
the Company will reimburse each such Holder, underwriter, controlling Person or other aforementioned Person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage,
liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 1.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, action or
proceeding if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the 

  
 13 

 
Company be liable in any such case for any such loss, claim, damage, liability, action or proceeding to the extent that it arises out of or is based upon a Violation that occurs in reliance upon
and in conformity with written information furnished expressly for use in connection with such registration by any such Holder, underwriter, controlling Person or other aforementioned Person. 

(b) To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the
Company, each of its directors, each of its officers who has signed the registration statement, each Person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the Company, any underwriter, any other
Holder selling securities in such registration statement and any controlling Person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing Persons may become
subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar as such losses, claims, damages or liabilities (or actions or proceedings,
whether commenced or threatened, in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished
by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any Person intended to be indemnified pursuant to this subsection 1.9(b) for any legal or other expenses reasonably incurred by such Person in
connection with investigating or defending any such loss, claim, damage, liability, action or proceeding as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 1.9(b) shall not apply
to amounts paid in settlement of any such loss, claim, damage, liability, action or proceeding if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), and provided that in no event
shall any indemnity under this subsection 1.9(b) exceed the net proceeds from the offering received by such Holder. 
 (c)
Promptly after receipt by an indemnified party under this Section 1.9 of notice of the commencement of any action or proceeding (including any governmental action or proceeding) for which a party may be entitled to indemnification, such
indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.9, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the
right to participate in and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided,
however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one (1) separate counsel, with the fees and expenses to be paid by
the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action or proceeding, if materially prejudicial to its ability to defend such
action or proceeding, shall relieve such indemnifying party of liability to the indemnified party under this Section 1.9 to the extent of such material prejudice, but the omission to so deliver written notice to the indemnifying party will not
relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.9. 

  
 14 

 
No indemnifying party, in the defense of any such action or proceeding, shall, except with the consent of each indemnified party, consent to entry of judgment or enter into any settlement which
does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such action or proceeding. 

(d) If the indemnification provided for in this Section 1.9 is held by a
non-appealable order from a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect
the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant
equitable considerations; provided, however, that (i) no contribution by any Holder, when combined with any amounts paid by such Holder pursuant to Section 1.9(b), shall exceed the net proceeds from the offering received by
such Holder and (ii) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and
provided further that in no event shall a Holder’s liability pursuant to this Section 1.9(d), when combined with the amounts paid or payable by such Holder pursuant to Section 1.9(b), exceed the proceeds from the
offering received by such Holder (net of any expenses paid by such Holder). The relative fault of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. 
 (e) Notwithstanding the foregoing, to the extent that
the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement
shall control. 
 (f) The obligations of the Company and Holders under this Section 1.9 shall survive the completion
of any offering of Registrable Securities in a registration statement under this Section 1 and otherwise shall survive the termination of this Agreement. 

1.10 Reports Under the 1934 Act. With a view to making available to the Holders the benefits of Rule 144 and any other
rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 

(a) make and keep adequate and current public information available, as those terms are understood and defined in Rule 144, at
all times after the effective date of the Initial Offering; 

  
 15 

 (b) file with the SEC in a timely manner all reports and other documents
required of the Company under the Act and the 1934 Act; and 
 (c) furnish to any Holder, so long as the Holder owns any
Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first registration
statement filed by the Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form
S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other
information as may be reasonably requested to avail any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 

1.11 Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to
this Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is an Affiliate, subsidiary, parent, partner, limited partner, retired partner, member,
equityholder, retired member or equityholder of a Holder, (ii) is a Holder’s family member or trust established for the benefit of an individual Holder, or (iii) after such assignment or transfer, holds at least fifty thousand
(50,000) shares of Registrable Securities (appropriately adjusted for any stock split, dividend, combination or other recapitalization), provided that: (a) the Company is, within a reasonable time after such transfer, furnished with
written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; (b) such transferee or assignee agrees in writing to be bound by and subject to the
terms and conditions of this Agreement, including, without limitation, the provisions of Section 1.13 below; and (c) such assignment shall be effective only if immediately following such transfer the further disposition of such securities
by the transferee or assignee is restricted under the Act. 
 1.12 Limitations on Subsequent Registration Rights.
From and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders holding a majority of the Registrable Securities then held by all Holders, enter into any agreement with any holder or prospective
holder of any securities of the Company that would allow such holder or prospective holder (a) to include any of such securities in any registration filed under Section 1.2, Section 1.3 or Section 1.4 hereof, unless under the
terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will not reduce the amount of the Registrable Securities of the Holders that are
included, or (b) to demand registration of their securities. 
 1.13 “Market
Stand-Off” Agreement. 
 (a) Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company’s Initial Offering and ending on the date specified by the Company and the managing
underwriter (such period not to exceed one hundred eighty (180) days) (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, 

  
 16 

 
purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock held immediately prior to the effectiveness of the Registration Statement for such offering, or (ii) enter into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise. The
foregoing provisions of this Section 1.13 shall apply only to the Company’s Initial Offering, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, or to any shares purchased in the Initial
Offering or in the secondary market following effectiveness of the registration statement relating to the Initial Offering, and shall only be applicable to the Holders if all officers, directors and greater than one percent (1%) stockholders of the
Company enter into similar agreements. The underwriters in connection with the Company’s Initial Offering are intended third-party beneficiaries of this Section 1.13 and shall have the right, power and authority to enforce the provisions
hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in the Company’s Initial Offering that are consistent with this Section 1.13 or that are
necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply to all Holders subject to such agreements pro rata based on the
number of shares subject to such agreements. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other Person
subject to the foregoing restriction) until the end of such period. Notwithstanding the foregoing, if the Company is not an “Emerging Growth Company” as defined under the Jumpstart Our Business Startups (JOBS) Act of 2012 at the time of
its Initial Offering, and (i) during the last seventeen (17) days of the one hundred eighty (180)-day restricted period, the Company issues an earnings release or material news or a material event
relating to the Company occurs; or (ii) prior to the expiration of the one hundred eighty (180)-day restricted period, the Company announces that it will release earnings results during the sixteen (16)-day period beginning on the last day of the one hundred eighty (180)-day period, the restrictions imposed by this Section 1.13 shall continue to apply until the
expiration of the eighteen (18)-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event. 

(b) Each Holder agrees that a legend reading substantially as follows shall be placed on all certificates representing all
Registrable Securities of each Holder (and the shares or securities of every other Person subject to the restriction contained in this Section 1.13): 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER
THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S
PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 

  
 17 

 1.14 Termination of Registration Rights. No Holder shall be entitled
to exercise any right provided for in this Section 1 (including a Shelf Take-Down or an Underwritten Takedown) (a) after three (3) years following the consummation of the Initial Offering, (b) as to any Holder, such earlier time
after the Initial Offering at which such Holder (i) can sell all shares held by it in compliance with Rule 144(b)(1)(i) and (ii) holds one percent (1%) or less of the Company’s outstanding Common Stock and all Registrable Securities
held by such Holder (together with any Affiliate of the Holder with whom such Holder must aggregate its sales under Rule 144) can be sold in any three (3) month period without registration in compliance with Rule 144 and without any limitations
as to volume or manner of sale, or (c) after the consummation of a Liquidation Event, as that term is defined in the Restated Certificate. The Company shall be permitted to withdraw a Shelf Registration on the earlier to occur of the dates
specified in clauses (a) and (b) in the previous sentence. 
 2. Covenants of the Company. 

2.1 Delivery of Financial Statements. 

(a) The Company shall, upon request, deliver to (i) each Investor (or transferee of an Investor) that holds at least
2,000,000 shares of Registrable Securities (appropriately adjusted for any stock split, dividend, combination or other recapitalization), (ii) so long as the Wellington Investors collectively hold at least a majority of shares of Series G Preferred
Stock originally acquired by the Wellington Investors, each Wellington Investor and (iii) so long as General Atlantic holds at least a majority of shares of Series H Preferred Stock acquired by General Atlantic at the Initial Closing (as such
term is defined in the Series H Agreement), General Atlantic (each, a “Major Investor”): 
 (i) as soon as
practicable, but in any event within one hundred eighty (180) days after the end of each fiscal year of the Company, an income statement for such fiscal year, a balance sheet of the Company and statement of stockholders’ equity as of the
end of such year, and a statement of cash flows for such year, such year-end financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles
(“GAAP”), and audited and certified by independent public accountants of nationally recognized standing selected by the Company; 

(ii) as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three
(3) quarters of each fiscal year of the Company, (A) an unaudited income statement, statement of cash flows for such fiscal quarter and an unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal
quarter, all prepared in accordance with GAAP (except that such financial statements may (x) be subject to normal year-end audit adjustments and (y) not contain all notes thereto that may be required
in accordance with GAAP) and (B) a statement detailing the gross merchandise value calculations for the trailing twelve-month period measured as of the last day of a calendar quarter; 

(iii) within thirty (30) days of the end of each month, an unaudited income statement and statement of cash flows for
such month, and an unaudited balance sheet as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments
and (ii) not contain all notes thereto that may be required in accordance with GAAP); 

  
 18 

 (iv) as soon as practicable, a capitalization table showing the
fully-diluted capitalization of the Company and each holder of securities of the Company; 
 (v) such other information
relating to the financial condition, business or corporate affairs of the Company or any subsidiary of the Company as any Major Investor may from time to time reasonably request (including, an annual budget and operating plans, monthly reports of
key performance indicators (KPIs), and such other report prepared for the Company’s management and/or any Investors); provided, however, that the Company shall not be obligated under this subsection (v) or any other
subsection of Section 2.1 to provide information that (A) it deems in good faith to be a trade secret or similar confidential information or (B) the disclosure of which would adversely affect the attorney-client privilege between the
Company and its counsel. 
 (b) If, for any period, the Company has any subsidiary whose accounts are consolidated with
those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

(c) Notwithstanding anything else in this Section 2.1 to the contrary, the Company may cease providing the information
set forth in this Section 2.1 during the period starting with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with
the SEC rules applicable to such registration statement and related offering; provided that the Company’s covenants under this Section 2.1 shall be reinstated at such time as the Company is no longer actively employing its
commercially reasonable efforts to cause such registration statement to become effective. 
 2.2 Inspection. 

(a) The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the
Company’s and its subsidiaries’ properties, to examine their books of account and records and to discuss the Company’s and its subsidiaries’ affairs, finances and accounts with their respective officers, all at such reasonable
times as may be requested by the applicable Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 2.2 to provide access to any information that (A) it reasonably deems in good
faith to be a trade secret or similar confidential information or (B) the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. 

(b) Each Investor acknowledges and understands that, but for the waiver made herein, such Investor would be entitled, upon
written demand under oath stating the purpose thereof, to inspect for any proper purpose, and to make copies and extracts from, the Company’s stock ledger, a list of its stockholders, and its other books and records, and the books and records
of subsidiaries of the Company, if any, under the circumstances and in the manner 

  
 19 

 
provided in Section 220 of the General Corporation Law of Delaware (any and all such rights, and any and all such other rights of such Investor as may be provided for in Section 220,
the “Inspection Rights”). In light of the foregoing, until the Initial Offering, each Investor hereby unconditionally and irrevocably waives the Inspection Rights, whether such Inspection Rights would be exercised or pursued
directly or indirectly pursuant to Section 220 or otherwise, and covenants and agrees never to directly or indirectly commence, voluntarily aid in any way, prosecute, assign, transfer, or cause to be commenced any claim, action, cause of
action, or other proceeding to pursue or exercise the Inspection Rights. The foregoing waiver applies to the Inspection Rights of each Investor in such Investor’s capacity as a stockholder and shall not affect any rights of a director, in his
or her capacity as such, under Section 220. The foregoing waiver shall not apply to any contractual inspection rights of an Investor under any written agreement with the Company. 

2.3 Termination of Information and Inspection Covenants. The covenants set forth in Sections 2.1 and 2.2 shall
terminate and be of no further force or effect upon the earlier to occur of (a) the consummation of the sale of securities pursuant to a registration statement filed by the Company under the Act in connection with the firm commitment
underwritten offering of its securities to the general public, (b) when the Company first becomes subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the 1934 Act, and (c) the consummation of a Liquidation Event,
as that term is defined in the Restated Certificate. 
 2.4 Right of First Offer. Subject to the terms and conditions
specified in this Section 2.4, the Company hereby grants to each Major Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). For purposes of this Section 2.4, the term
“Major Investor” includes any general partners and Affiliates of a Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted it among itself and its partners and Affiliates in such
proportions as it deems appropriate. 
 Each time the Company proposes to offer any shares of, or securities convertible
into or exchangeable or exercisable for any shares of, its capital stock (“Shares”), the Company shall first make an offering of such Shares to each Major Investor in accordance with the following provisions: 

(a) The Company shall deliver a notice in accordance with Section 3.5 (“Notice”) to the Major Investors
stating (i) its bona fide intention to offer such Shares, (ii) the number of such Shares to be offered and (iii) the price and terms upon which it proposes to offer such Shares. 

(b) By written notification received by the Company within twenty (20) calendar days after the giving of Notice, each
Major Investor may elect to purchase, at the price and on the terms specified in the Notice, up to that portion of such Shares that equals the proportion that the number of shares of Common Stock that are Registrable Securities issued and held by
such Major Investor (assuming full conversion and exercise of all convertible and exercisable securities then outstanding) bears to the total number of shares of Common Stock of the Company then outstanding (assuming full conversion and exercise of
all convertible and exercisable securities then outstanding). The Company shall promptly, in writing, inform each Major Investor that elects to purchase all the shares available to it (a “Fully-Exercising Investor”) 

  
 20 

 
of any other Major Investor’s failure to do likewise. During the ten (10) day period commencing after such information is given to the Fully-Exercising Investors, each Fully-Exercising
Investor may elect to purchase that portion of the Shares for which Major Investors were entitled to subscribe, but which were not subscribed for by the Major Investors, that is equal to the proportion that the number of shares of Registrable
Securities issued and held by such Fully-Exercising Investor bears to the total number of shares of Common Stock issued and held, or issuable upon conversion of the Preferred Stock then held, by all Fully-Exercising Investors who wish to purchase
some of the unsubscribed Shares. 
 (c) If all Shares that Major Investors are entitled to obtain pursuant to subsection
2.4(b) are not elected to be obtained as provided in subsection 2.4(b) hereof, the Company may, during the ninety (90) day period following the expiration of the period provided in subsection 2.4(b) hereof, offer the remaining unsubscribed
portion of such Shares to any Person or Persons at a price not less than that, and upon terms no more favorable to the offeree than those, specified in the Notice. If the Company does not enter into an agreement for the sale of the Shares within
such period, or if such agreement is not consummated within sixty (60) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major Investors
in accordance herewith. 
 (d) The right of first offer in this Section 2.4 shall not be applicable to (i) the
issuance or sale of shares of Common Stock (or options therefor) (appropriately adjusted for any stock split, dividend, combination or other recapitalization) to employees, directors, consultants and other service providers for the primary purpose
of soliciting or retaining their services pursuant to plans or agreements approved by the Board, (ii) the issuance of securities pursuant to a bona fide, firmly underwritten public offering of shares of Common Stock registered under the Act,
(iii) the issuance of securities pursuant to the conversion or exercise of convertible or exercisable securities, (iv) the issuance of securities as consideration in connection with a bona fide business acquisition by the Company, whether
by merger, consolidation, sale of assets, sale or exchange of stock or otherwise, which is approved by the Board, (v) the issuance and sale of Series H Preferred Stock and/or Common Stock pursuant to the Series H Agreement, (vi) the
issuance of stock, warrants or other securities or rights to Persons or entities with which the Company has business relationships, provided such issuances are primarily for other than equity financing purposes, (vii) the issuance of
stock, warrants or other securities or rights pursuant to any equipment leasing arrangement or debt financing arrangement, which arrangement is approved by the Board and is primarily for non-equity financing
purposes or (viii) the issuance of securities that are specifically deemed not to be subject to the right of first offer in this Section 2.4 by the unanimous approval of the Board. In addition to the foregoing, the right of first offer in
this Section 2.4 shall not be applicable with respect to any Major Investor in any subsequent offering of Shares if (A) at the time of such offering, the Major Investor is not an “accredited investor,” as that term is then
defined in Rule 501(a) of the Act and (B) such offering of Shares is otherwise being offered only to accredited investors. 

(e) The rights provided in this Section 2.4 may not be assigned or transferred by any Major Investor; provided,
however, that a Major Investor that is an investment firm or vehicle may assign or transfer all or a portion of such rights to its general partners or Affiliates. 

  
 21 

 (f) The covenants set forth in this Section 2.4 shall terminate and be
of no further force or effect upon the consummation of the earlier of (i) the Company’s sale of its Common Stock or other securities pursuant to Registration Statement under the Act (other than a registration statement relating either to
the sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145 transaction) and (ii) a Liquidation Event, as that term is defined in the Restated Certificate. 

2.5 Proprietary Information and Inventions Agreements. The Company shall, and shall cause its subsidiaries to, require
all employees, officers and consultants with access to confidential information to execute and deliver a Proprietary Information and Inventions Agreement (in the case of employees and officers), or a Consulting Agreement (in the case of
consultants), in each case in substantially the form approved by the Board. 
 2.6 Successor Indemnification. If the
Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be
made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board as in effect immediately before such transaction, whether such obligations are contained in the
Company’s Bylaws, its Restated Certificate, or elsewhere, as the case may be. 
 2.7 FCPA. The Company
represents that it shall not, and shall not permit any of its subsidiaries or affiliates or any of its or their respective directors, officers, managers, employees, independent contractors, representatives or agents to, promise, authorize or make
any payment to, or otherwise contribute any item of value to, directly or indirectly, any Non-U.S. Official, in each case, in violation of the Foreign Corrupt Practices Act of 1977, as amended (the
“FCPA”), the UK Bribery Act 2010 (the “UK Bribery Act”) or any other applicable anti-bribery or anti-corruption law. The Company further represents that it shall, and shall cause each of its subsidiaries and affiliates to,
cease all of its or their respective activities, as well as remediate any actions taken by the Company, its subsidiaries or affiliates, or any of their respective directors, officers, managers, employees, independent contractors, representatives or
agents in violation of the FCPA, the UK Bribery Act or any other applicable anti-bribery or anti-corruption law. 
 2.8
Confidentiality. Each Investor agrees that such Investor will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the
Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file a registration statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a
result of a breach of this Subsection 2.8 by such Investor), (b) is or has been independently developed or conceived by the Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to
the Investor by a third party without a breach of any obligation of confidentiality such third party has to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants,
and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective
purchaser agrees to be bound by the provisions of this Subsection 2.8; (iii) to (A) any current or prospective Affiliate, 

  
 22 

 
partner, partner of a partner, member, stockholder, or wholly owned subsidiary of such Investor or (B) any prospective limited partner of an investment entity formed (or to be formed) after
the date hereof that is an advisory or subadvisory client of Wellington, in each case, in the ordinary course of business, provided that such Investor informs such Person that such information is confidential and directs such Person to maintain the
confidentiality of such information and that such Person is bound by binding confidentiality obligations; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the Company of such disclosure and takes
reasonable steps to minimize the extent of any such required disclosure. 
 2.9 Termination of Certain Covenants. The
covenants set forth in Section 2.5 and 2.7 shall terminate and be of no further force or effect upon the consummation of the earlier of (a) the Company’s sale of its Common Stock or other securities pursuant to Registration Statement
under the Act (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a transaction under Rule 145 of the Act) and (b) a
Liquidation Event, as that term is defined in the Restated Certificate. 
 3. Miscellaneous. 

3.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other
than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

3.2 Governing Law. This Agreement shall be governed by and construed under the laws of the State of California as
applied to agreements among California residents entered into and to be performed entirely within California. 
 3.3
Counterparts; Facsimile. This Agreement may be executed and delivered by facsimile or electronic signature and in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one
(1) and the same instrument. 
 3.4 Titles and Subtitles. The titles and subtitles used in this Agreement are
used for convenience only and are not to be considered in construing or interpreting this Agreement. 
 3.5 Notices.
All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively given upon the earlier to occur of actual receipt or: (a) upon personal delivery to the party to be notified, (b) when
sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day domestic delivery, with written verification of receipt or (e) three (3) days after deposit with an internationally
recognized 

  
 23 

 
overnight courier, specifying next day international delivery, with written verification of receipt. All notices and other communications shall be sent to the Company at One Sansome Street, 40th Floor, San Francisco, CA 94111, Attention: CEO and to the other parties at the addresses set forth in the Company’s books and records (or at such other addresses as shall be specified by notice
given in accordance with this Section 3.5). 
 3.6 Expenses. If any action at law or in equity is necessary to
enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

3.7 Entire Agreement; Amendments and Waivers. This Agreement (including the Exhibits hereto, if any) constitutes the
full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof. Any term of this Agreement (except Section 1.1(g), Section 1.1(j), Section 1.1(n), Section 1.1(t), Section 1.1(u),
Section 1.1(v), Section 1.1(w), Section 1.1(x) and Section 1.1(y), Section 2.1, Section 2.2, Section 2.3, and Section 2.4) may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Investors holding a majority of the Registrable Securities. The provisions of Section 1.1(n) and this sentence
may be amended or waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Requisite Parties. The provisions of Section 1.1(t) may be amended or waived
(either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Series F Requisite Holders. The provisions of Sections 1.1(u) and 1.1(v) may be amended, terminated or
waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Series G Requisite Holders. The provisions of Sections 1.1(m) and 1.1(w) and this sentence may be
amended or waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Series H Requisite Holders. The provisions of Section 1.1(j) and this sentence may
be amended, terminated or waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company, the Series F Requisite Holders, the Series G Requisite Holders and the Series H
Requisite Holders. The provisions of Section 2.1, Section 2.2, Section 2.3 and Section 2.4 and this sentence may be amended, terminated or waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the Major Investors holding a majority of the Registrable Securities then held by all of the Major Investors; provided that, notwithstanding any waiver of the provisions of
Section 2.4 with respect to a particular offering, if any of the Major Investor actually purchases Shares in such offering, then each Major Investor that did not consent to such waiver shall be permitted to participate in such offering on a
pro rata basis with respect to the securities that are allocated for purchase by the Major Investor and in accordance with the other provisions (including notice and election periods) set forth in Section 2.4. The provisions of
Section 1.1(c) (as it relates to a Wellington Investor), Section 1.1(x), Section 1.1(y) and the definition of “Major Investor” in Section 2.1(a) (as it relates to a Wellington Investor) may be amended or waived (either
generally or in a particular instance and either retroactively or prospectively) only with the written consent of such Wellington Investor. The provisions of Section 1.1(g), the definition of “Major Investor” in

  
 24 

 
Section 2.1(a) (as it relates to General Atlantic) and this sentence may be amended or waived (either generally or in a particular instance and either retroactively or prospectively) only
with the written consent of General Atlantic. Further, this Agreement may not be amended, and no provision hereof may be waived, in each case, in any way which would adversely affect the rights or obligations of a Major Investor hereunder in a
manner disproportionate to any adverse effect such amendment or waiver would have on the rights of the other Major Investors hereunder, without also the written consent of such Major Investor. Any amendment or waiver effected in accordance with this
paragraph shall be binding upon each holder of any Registrable Securities, each future holder of all such Registrable Securities and the Company. 

3.8 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be
effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this Agreement. 
 3.9 Aggregation of
Stock. All shares of Registrable Securities held or acquired by a Holder’s Affiliates or affiliated entities (including affiliated venture capital funds or venture capital funds under common investment management) or Persons shall be
aggregated together for the purpose of determining the availability of any rights under this Agreement. 
 3.10
Additional Investors. Notwithstanding Section 3.7, no consent shall be necessary to add additional Investors as signatories to this Agreement, provided that such Investors have purchased Series H Preferred Stock pursuant to the
subsequent closing provisions of Section 1.3 of the Series H Agreement. 
 3.11 Dispute Resolution. Any
unresolved controversy or claim arising out of or relating to this Agreement, except as (a) otherwise provided in this Agreement, or (b) any such controversies or claims arising out of either party’s intellectual property rights for
which a provisional remedy or equitable relief is sought, shall be submitted to arbitration by one arbitrator mutually agreed upon by the parties, and if no agreement can be reached within thirty (30) days after names of potential arbitrators
have been proposed by the American Arbitration Association (the “AAA”), then by one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement and who is chosen by the AAA.
The arbitration shall take place in San Francisco, California, in accordance with the AAA rules then in effect, and judgment upon any award rendered in such arbitration will be binding and may be entered in any court having jurisdiction thereof.
There shall be limited discovery prior to the arbitration hearing as follows: (a) exchange of witness lists and copies of documentary evidence and documents relating to or arising out of the issues to be arbitrated, (b) depositions of all
party witnesses and (c) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the California Code of Civil Procedure, the arbitrator shall be required to
provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. 

  
 25 

 3.12 Acknowledgment. The Company acknowledges that the Investors are
in the business of venture capital and/or private equity and other investing and therefore have general knowledge with respect to and review the business plans and related proprietary information of many enterprises, including enterprises which may
have products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement nor the receipt of confidential information shall preclude or in any way restrict the Investors from use of such general knowledge or
investing or participating in any particular enterprise whether or not such enterprise has products or services which compete with those of the Company. 

3.13 Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this
Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party
nor shall it be construed to be a waiver of any such breach or default, or an acquiescence thereto, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach
or default previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provision or
condition of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. 

3.14 Specific Enforcement. It is agreed and understood that monetary damages would not adequately compensate an injured
party for the breach of this Agreement by any other party hereto, that this Agreement shall be specifically enforceable, and that any breach or threatened breach of this Agreement shall be the proper subject of a temporary or permanent injunction or
restraining order. Further, each party hereto waives any claim or defense that there is an adequate remedy at law for such breach or threatened breach. 

3.15 Effect on Prior Agreement. Upon the effectiveness of this Agreement, the Prior Agreement shall be superseded and
replaced in its entirety by this Agreement and shall be of no further force or effect. 
 [Signature Page to Follow] 

  
 26 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 COMPANY

		
	 By:
	 	 /s/ Piotr Szulczewski

		 	 Piotr Szulczewski, CEO

  

					
		 	 Address:
	  	 1 Sansome St. 40th Floor

		 		  	 San Francisco, CA 94104

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 GGV CAPITAL IV L.P.

		
	 By:
	 	 GGV Capital IV L.L.C., its General Partner

		
	 By:
	 	 /s/ Hans Tung

		 	 Hans Tung, Managing Director

  

			
	 GGV CAPITAL IV ENTREPRENEURS FUND L.P.

		
	 By:
	 	 GGV Capital IV L.L.C., its General Partner

		
	 By:
	 	 /s/ Hans Tung

		 	 Hans Tung, Managing Director

  

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 GGV CAPITAL SELECT L.P.

		
	 By:
	 	 GGV Capital Select L.L.C., its General Partner

		
		 	 By: GGV Management, L.L.C., its Manager

		
	 By:
	 	 /s/ Hans Tung

		 	 Hans Tung, Manager

  

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 THE FOUNDERS FUND V, LP

		
	 By:
	 	 /s/ Brian
Singerman

 
			
	 Name:
	 	Brian Singerman

 
			
	Title:	 	 Managing Member

  

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 THE FOUNDERS FUND V PRINCIPALS FUND, LP

		
	 By:
	 	 /s/ Brian
Singerman

 
			
	 Name:
	 	Brian Singerman

 
			
	Title:	 	 Managing Member

  

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 THE FOUNDERS FUND V ENTREPRENEURS FUND, LP

		
	 By:
	 	 /s/ Brian
Singerman

 
			
	 Name:
	 	 Brian Singerman

 
			
	 Title:
	 	 Managing Member

  

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 FORMATION8 PARTNERS FUND I, L.P.

		
	 By
	 	 Formation8 GP, LLC

Its General Partner

		
	 By:
	 	 /s/ Joe Lonsdale

	 Name:
	 	 Joe Lonsdale

	 Title:
	 	 Managing Member

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 CL SPV, L.P.

		
	 By
	 	 Eight Partners VC GP I, LLC

Its General Partner

		
	 By:
	 	 /s/ Joe Lonsdale

	 Name:
	 	 Joe Lonsdale

	 Title:
	 	 Managing Member

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

		
	 By:
	 	 Wellington Management Company LLP, as investment adviser

		
	 By:
	 	 /s/ Emily D. Babalas

		 	 Name: Emily D. Babalas

		 	 Title: Managing Director and Counsel

	
	 Address for notice, which shall be set forth in the Company’s books and records:

	
	 Wellington Management Company LLP

Legal and Compliance

[Address]

	
	 With a copy (which shall not constitute notice) to:

	
	 WilmerHale LLP

[Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’
Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 RAHUL RAVINDRA RAJ MEHTA AND PARUL MEHTA JTWROS

		
	 By:
	 	 /s/ Rahul Mehta

		 	 Name: Rahul Mehta

		 	 Title Managing Member

		
	 By:
	 	 /s/ Parul Jtwros

		 	 Name: Parul Jtwros

		 	 Title Managing Member

 
			
		
	 Address:
	 	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 REDBYTE LIMITED

		
	 By:
	 	 /s/ Despoina Zinonos

	 Name:
	 	 Despoina Zinonos

	 Title:
	 	 Director

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 APOLETTO LIMITED

		
	 By:
	 	 /s/ Elena Azarenko

		 	 Name: Elena Azarenko

		 	 Title: Director

	
	 [Address] 

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 DST GLOBAL V, L.P.

		
	 By:
	 	 DST Managers Limited

Its: General Partner

		
	 By:
	 	 /s/ Despoina Zinonos

		 	 Name: Despoina Zinonos

		 	 Title: Director

	
	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	DST GLOBAL IV, L.P.
		
	By:	 	 DST Managers Limited
 Its: General
Partner

		
	By:	 	/s/ Despoina Zinonos
		 	Name: Despoina Zinonos
		 	Title: Director
	
	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 DST GLOBAL IV CO-INVEST, L.P.

		
	 By:
	 	 DST Managers Limited

Its: General Partner

		
	 By:
	 	 /s/ Despoina Zinonos

		 	 Name: Despoina Zinonos

		 	 Title: Director

	
	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 DST TEAM FUND LIMITED

		
	 By:
	 	 /s/ Despoina Zinonos

		 	 Name: Despoina Zinonos

		 	 Title: Director

	
	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	
	 INVESTORS:

	
	 DST INVESTMENTS XI, L.P.

		
	 By:
	 	 DST Managers Limited

Its: General Partner

		
	 By:
	 	 /s/ Despoina Zinonos

		 	 Name: Despoina Zinonos

		 	 Title: Director

		
		 	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	
	 INVESTORS:

	
	 DST INVESTMENTS XV, L.P.

		
	 By:
	 	 DST Managers V Limited

Its: General Partner

		
	 By:
	 	 /s/ Despoina Zinonos

		 	 Name: Despoina Zinonos

		 	 Title: Director

		
		 	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	
	 INVESTORS:

	
	 DST INVESTMENTS XVI, L.P.

		
	 By:
	 	 DST Managers V Limited

Its: General Partner

		
	 By:
	 	 /s/ Despoina Zinonos

		 	 Name: Despoina Zinonos

		 	 Title: Director

		
		 	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTORS:

	
	 REPUBLIC TECHNOLOGIES PTE. LTD.

		
	 By:
	 	 /s/ Ang Peng Huat

	 Name:
	 	 Ang Peng Huat

	 Title:
	 	 Authorized Signatory

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	 INVESTOR:

	
	 GENERAL ATLANTIC (WI), L.P.

		
	 By:
	 	 General Atlantic (SPV) GP, LLC, 

its general partner

		
	 By:
	 	 General Atlantic LLC, 

its sole member

		
	 By:
	 	 /s/ J. Frank Brown

	 Name:
	 	 J. Frank Brown

	 Title:
	 	 Managing Director

	
	 Address for notice, which shall be set forth in the Company’s books and records:

	
	 [Address]

  

SIGNATURE PAGE TO AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT 
 FOR
CONTEXTLOGIC INC.EX-4.3

 Exhibit 4.3 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE
COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT. 
 Date of Issuance 

August 1, 2016  

CONTEXTLOGIC INC. 

WARRANT TO PURCHASE SHARES OF SERIES B PREFERRED STOCK 

For the purchase price of $3,897,129.34, this Warrant is issued to Formation8 Partners Fund I, L.P. or its assigns (the
“Holder”) by CONTEXTLOGIC INC., a Delaware corporation (the “Company”). 
 1. Purchase of
Shares. 
 (a) Number of Shares. Subject to the terms and conditions set forth herein, the Holder is
entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder in writing), to purchase from the Company up to 986,640 fully paid and nonassessable shares of the
Company’s Series B Preferred Stock, par value $0.0001 per share (the “Preferred Stock”). 
 (b) Exercise
Price. The exercise price for the shares of Preferred Stock issuable pursuant to this Section 1 (the “Shares”) shall be $0.0001 per share (the “Exercise Price”). The Shares and the Exercise Price shall be subject to
adjustment pursuant to Section 8 hereof. 
 2. Exercise Period. This Warrant shall only be exercisable one day
prior to the earliest to occur of (a) the consummation of the Company’s sale of its Common Stock or other securities in the Company’s first underwritten public offering pursuant to an effective registration statement under the
Securities Act of 1933, as amended (the “Act”) (other than a registration statement relating either to sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145
transaction) (an “Initial Public Offering”) and (b) the consummation of a Liquidation Event, as such term is defined in the Company’s Amended and Restated Certificate of Incorporation on file with the Secretary of State of the
State of Delaware. For purposes of this Warrant, any of the transactions described in subsection (b) shall be referred to herein as a “Corporate Transaction”. In the event of an Initial Public Offering or Corporate Transaction, the
Company shall notify the Holder at least three (3) days prior to the consummation of such Initial Public Offering or Corporate Transaction. 

 
Notwithstanding anything to the contrary in this Warrant, if Holder fails to purchase a Note within sixty days of the Date of Issuance pursuant to Section 2 of the Settlement and Release
Agreement between the Company and Holder of even date herewith, then this Warrant shall terminate and shall not be exercisable for any Shares. 

3. Method of Exercise. 

(a) While this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise,
in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: 
 (i) the surrender of the
Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and 

(ii) except in the case of a Net Exercise (as defined in Section 4), the payment to the Company of an amount equal to
the aggregate Exercise Price for the number of Shares being purchased. 
 (b) Each exercise of this Warrant shall be deemed
to have been effected immediately prior to the close of business on the day on which this Warrant is surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name or names any certificate for
the Shares shall be issuable upon such exercise as provided in Section 3(c) below shall be deemed to have become the holder or holders of record of the Shares represented by such certificate. 

(c) As soon as practicable after the exercise of this Warrant in whole or in part the Company at its expense will cause to be
issued in the name of, and delivered to, the Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct: 

(i) a certificate or certificates for the number of Shares to which such Holder shall be entitled, and 

(ii) in case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the
aggregate on the face or faces thereof for the number of Shares equal to the number of such Shares described in this Warrant minus the number of such Shares purchased by the Holder upon all exercises made in accordance with Section 3(a) above
or Section 4 below. 
 (d) Notwithstanding the provisions of Section 2, if the holder has not exercised this
Warrant prior to the closing of a Corporate Transaction or an Initial Public Offering, this Warrant shall automatically be deemed to be exercised in full in the manner set forth in Section 4, without any further action on behalf of the Holder
immediately prior to such closing. 

 4. Net Exercise. In lieu of exercising this Warrant for cash, the
Holder may elect to receive shares equal to the value of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together with notice of such election (a “Net Exercise”). A
Holder who Net Exercises shall have the rights described in Sections 3(b) and 3(c) hereof, and the Company shall issue to such Holder a number of Shares computed using the following formula:  

 

	
	X = Y (A - B)
	A

 Where 

X = The number of Shares to be issued to the Holder. 

Y = The number of Shares purchasable under this Warrant or, if only a portion of the Warrant is being
exercised, the portion of the Warrant being exercised (at the date of such calculation). 
 A = The fair market value of one
(1) Share (at the date of such calculation). 
 B = The Exercise Price (as adjusted to the date of such calculation).

 For purposes of this Section 4, the fair market value of a Share shall mean the average of the closing prices of the
Shares (or equivalent shares of Common Stock underlying this Warrant) quoted in the over-the-counter market in which the Shares (or equivalent shares of Common Stock
underlying the Warrant) are traded or the closing price quoted on any exchange or electronic securities market on which the Shares (or equivalent shares of Common Stock underlying the Warrant) are listed, whichever is applicable, as published in
The Wall Street Journal for the thirty (30) trading days prior to the date of determination of fair market value (or such shorter period of time during which such Shares were traded over-the-counter or on such exchange). In the event that this Warrant is exercised pursuant to this Section 4 in connection with the Initial Public Offering, the fair market value per Share shall be the
product of (a) the per share offering price to the public of the Initial Public Offering, and (b) the number of shares of Common Stock into which each Share is convertible at the time of such exercise. If the Shares are not traded on the over-the-counter market, an exchange or an electronic securities market, the fair market value shall be the price per Share that the Company could obtain from a willing buyer
for Shares sold by the Company from authorized but unissued Shares, as such prices shall be determined in good faith by the Company’s Board of Directors. 

5. Representations and Warranties of the Company. In connection with the transactions provided for herein, the Company
hereby represents and warrants to the Holder that: 
 (a) Organization, Good Standing, and Qualification. The Company
is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted. The Company is duly qualified to transact
business and is in good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties. 

 (b) Authorization. Except as may be limited by applicable bankruptcy,
insolvency, reorganization or similar laws relating to or affecting the enforcement of creditors’ rights, all corporate action has been taken on the part of the Company, its officers, directors, and stockholders necessary for the authorization,
execution and delivery of this Warrant. The Company has taken all corporate action required to make all the obligations of the Company reflected in the provisions of this Warrant the valid and enforceable obligations they purport to be. The issuance
of this Warrant will not be subject to preemptive rights of any stockholders of the Company. The Company has authorized sufficient shares of Preferred Stock to allow for the exercise of this Warrant. 

6. Representations and Warranties of the Holder. In connection with the transactions provided for herein, the Holder
hereby represents and warrants to the Company that: 
 (a) Authorization. Holder represents that it has full power and
authority to enter into this Warrant. This Warrant constitutes the Holder’s valid and legally binding obligation, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy, insolvency, reorganization,
or similar laws relating to or affecting the enforcement of creditors’ rights and (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies. 

(b) Purchase Entirely for Own Account. The Holder acknowledges that this Warrant is entered into by the Holder in
reliance upon such Holder’s representation to the Company that the Warrant and the Shares, and the Common Stock issuable upon conversion of the Shares, (collectively, the “Securities”) will be acquired for investment for the
Holder’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in or otherwise distributing the same.
By acknowledging this Warrant, the Holder further represents that the Holder does not have any contract, undertaking, agreement, or arrangement with any person to sell, transfer or grant participations to such person or to any third person, with
respect to the Securities. 
 (c) Disclosure of Information. The Holder acknowledges that it has received all the
information it considers necessary or appropriate for deciding whether to acquire the Securities. The Holder further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions
of the offering of the Securities. 
 (d) Investment Experience. The Holder is an investor in securities of companies
in the development stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks
of the investment in the Securities. If other than an individual, the Holder also represents it has not been organized solely for the purpose of acquiring the Securities. 

 (e) Accredited Investor. The Holder is an “accredited
investor” within the meaning of Rule 501 of Regulation D, as presently in effect, as promulgated by the Securities and Exchange Commission (the “SEC”) under the Act. 

(f) Restricted Securities. The Holder understands that the Securities are characterized as “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without
registration under the Act, only in certain limited circumstances. In this connection, the Holder represents that it is familiar with Rule 144, as presently in effect, as promulgated by the SEC under the Act (“Rule 144”), and understands
the resale limitations imposed thereby and by the Act. 
 (g) Further Limitations on Disposition. Without in any way
limiting the representations set forth above, the Holder further agrees not to make any disposition of all or any portion of the Shares unless and until the transferee has agreed in writing for the benefit of the Company to be bound by the terms of
this Warrant, including, without limitation, this Section 6, Section 21, and: 
 (i) there is then in effect a
registration statement under the Act covering such proposed disposition and such disposition is made in accordance with such registration statement; 

(ii) the Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a
detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such
disposition will not require registration of such shares under the Act. It is agreed that the Company will not require opinions of counsel for transactions made pursuant to Rule 144 except in extraordinary circumstances; or 

(iii) the Holder shall not make any disposition to any of the Company’s competitors as such is reasonably
determined by the Company. 
 (h) Legends. It is understood that the Securities may bear the following legend: 

“THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR
SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER
SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.” 

 7. State Commissioners of Corporations. THE SALE OF THE SECURITIES
WHICH ARE THE SUBJECT OF THIS WARRANT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION FOR SUCH SECURITIES PRIOR TO
SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT ARE EXPRESSLY CONDITIONED UPON SUCH
QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. 
 8. Adjustment of Exercise Price and Number of Shares.
The number and kind of Shares purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 

(a) Subdivisions, Combinations and Other Issuances. If the Company shall at any time after the issuance but prior to the
expiration of this Warrant subdivide its Preferred Stock, by split-up or otherwise, or combine its Preferred Stock, or issue additional shares of its Preferred Stock or Common Stock as a dividend with respect
to any shares of its Preferred Stock, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a
combination. Appropriate adjustments shall also be made to the Exercise Price payable per share, but the aggregate Exercise Price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any
adjustment under this Section 8(a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the
making of such dividend. 
 (b) Reclassification, Reorganization and Consolidation. In case of any reclassification,
capital reorganization or change in the capital stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 8(a) above), then, as a condition of such reclassification, reorganization or
change, lawful provision shall be made, and duly executed documents evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration of this Warrant
to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification, reorganization or change by a holder
of the same number and type of securities as were purchasable as Shares by the Holder immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with respect to the rights and interest
of the Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made to the Exercise Price per
Share payable hereunder, provided the aggregate Exercise Price shall remain the same. 

 (c) Notice of Adjustment. When any adjustment is required to be made
in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Shares or other securities or property thereafter purchasable upon
exercise of this Warrant. 
 (d) Conversion of Preferred Stock. In the event that all outstanding shares of Preferred
Stock are converted to Common Stock, or any other security, in accordance with the terms of the Company’s Certificate of Incorporation in connection with the Company’s Initial Public Offering, Corporate Transaction or other event, this
Warrant shall become exercisable for Common Stock or such other security. 
 9. No Fractional Shares or Scrip. No
fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 

10. No Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a
stockholder with respect to the Shares, including (without limitation) the right to vote such Shares, receive dividends or other distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise
provided in this Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs of the Company. 

11. Transfer of Warrant. Subject to compliance with applicable federal and state securities laws and any other
contractual restrictions between the Company and the Holder contained herein, this Warrant and all rights hereunder are transferable in whole or in part by the Holder to any person or entity upon written notice to the Company. Within a reasonable
time after the Company’s receipt of an executed Assignment Form in the form attached hereto, the transfer shall be recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal
offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event of a partial transfer, the Company shall issue to the new holders one (1) or more appropriate new warrants. 

12. Governing Law. This Warrant shall be governed by and construed under the laws of the State of California as applied
to agreements among California residents, made and to be performed entirely within the State of California. 
 13.
Successors and Assigns. The terms and provisions of this Warrant shall inure to the benefit of, and be binding upon, the Company and the holders hereof and their respective successors and assigns. 

14. Counterparts. This Warrant may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. 
 15. Titles and Subtitles. The titles and
subtitles used in this Warrant are used for convenience only and are not to be considered in construing or interpreting this Warrant. 

 16. Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the
recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at the following addresses (or at such other addresses as shall be specified by notice given
in accordance with this Section 16): 
 If to the Company: 

CONTEXTLOGIC INC. 

One Sansome Street, 40th Floor San Francisco, CA 94104 

If to Holder: 

At the address shown on the signature page hereto. 

17. Finder’s Fee. Each party represents that it neither is or will be obligated for any finder’s fee or
commission in connection with this transaction. The Holder agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending
against such liability or asserted liability) for which the Holder or any of its officers, partners, employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Holder from any liability for any commission or
compensation in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible. 

18. Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant, the
prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

19. Entire Agreement; Amendments and Waivers. This Warrant and any other documents delivered pursuant hereto constitute
the full and entire understanding and agreement between the parties with regard to the subjects hereof and thereof. Nonetheless, any term of this Warrant may be amended and the observance of any term of this Warrant may be waived (either generally
or in a particular instance and either retroactively or prospectively), with the written consent of the Company and the Holder; or if this Warrant has been assigned in part, by the holders or rights to purchase a majority of the shares originally
issuable pursuant to this Warrant. 

 20. Severability. If any provision of this Warrant is held to be
unenforceable under applicable law, such provision shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

21. “Market Stand-Off” Agreement. The Shares shall be subject to the
“Market Stand-Off” Agreement contained in Section 1.13 of the Amended and Restated Investors’ Rights Agreement dated as of February 3, 2015 (as it may be amended). 

 IN WITNESS WHEREOF, the parties have executed this Warrant as of the date first written
above. 
  

			
	CONTEXTLOGIC INC.
		
	By:	 	/s/ Peter Szulczewski
		 	Peter Szulczewski, CEO
		
	Address:	 	1 Sansome St. 40th Floor
		 	 San Francisco, CA 94104

  

			
	ACKNOWLEDGED AND AGREED:
	
	 FORMATION8 PARTNERS FUND I, L.P.

By Formation8 GP, LLC
 Its General Partner

		
	By:	 	/s/ Joe Lonsdale
		
	Name:	 	Joe Lonsdale
		
	Title:	 	Managing Member
		
	Address:	 	 [Address]

		
		 	 

 NOTICE OF EXERCISE 

CONTEXTLOGIC INC. 
 Attention: Corporate Secretary 

The undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows: 

 

	 	☐	 _____________ shares of Series B Preferred Stock pursuant to the terms of the attached Warrant, and tenders
herewith payment in cash of the Exercise Price of such Shares in full, together with all applicable transfer taxes, if any. 

  

	 	☐	 Net Exercise the attached Warrant with respect to __________ Shares. 

The undersigned hereby represents and warrants that Representations and Warranties in Section 6 hereof are true and
correct as of the date hereof.  
  

									
		 		 		 	 HOLDER:

					
	 Date:___________________
	 		 		 	 By:
	 	 
				
		 		 	 Address:
	 	 
		 		 		 	 
		 		 		 	 
					
	 Name in which shares should be registered:
	 		 		 		 	
					
	 	 		 		 		 	

 ASSIGNMENT FORM 

(To assign the foregoing Warrant, execute 

this form and supply required information. 

Do not use this form to purchase shares.) 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to 

 

			
	 Name:
	 	 
		 	                                      
                                  (Please Print)
		
	 Address:
	 	 
		 	
                   
                                         
            (Please Print)

		
	 Dated:
	 	
                   
                     

		
	 Holder’s
	 	
	 Signature:
	 	
                   
                                         
                                  

		
	 Holder’s
	 	
	 Address:
	 	
                   
                                         
                                  

 NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of
the Warrant. Officers of corporations and those acting in a fiduciary or other representative capacity should provide proper evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]